Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

20
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
20
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

573
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
573
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

786
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
786
Vascular Resistance01:20

Vascular Resistance

4.3K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitigation of Hepatic and Pancreatic Injury by <i>Spondias tuberosa</i> Extract Through Oxidative Enzyme Modulation and TGF-β Downregulation.

Food science & nutrition·2026
Same author

Triple-Marker Screening of 20 Terpenes Identifies Candidate Modulators of Senescence-Associated Phenotypes in D-Galactose-Treated Endothelial Cells.

Molecules (Basel, Switzerland)·2026
Same author

Aging and DNA damage are associated with the development of endothelial cell clonal expansion.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Monoterpenes in Vascular Function: A Review of Bioactivity and Mechanisms of Action.

International journal of molecular sciences·2025
Same author

Multiple targets directed screening of compounds from northeastern Brazilian fruits with activity in oxidative stress pathways associated with vascular damage throughout ageing.

Natural product research·2025
Same author

Organic vs. inorganic nitrates: Metabolic and vascular outcomes in STZ-induced diabetes in mice.

Life sciences·2024

Related Experiment Video

Updated: Jul 23, 2025

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

9.4K

Carvacrol Improves Vascular Function in Hypertensive Animals by Modulating Endothelial Progenitor Cells.

Tays Amanda Felisberto Gonçalves1, Viviane Silva Lima1, Arthur José Pontes Oliveira de Almeida1

  • 1Department of Pharmaceutical Sciences, Federal University of Paraiba, João Pessoa 58059-900, PB, Brazil.

Nutrients
|July 14, 2023
PubMed
Summary

Carvacrol enhances endothelial progenitor cell (EPC) function, promoting vascular repair in hypertension. This natural compound improves blood vessel health by boosting EPCs and reducing oxidative stress.

Keywords:
endothelial dysfunctionendothelial progenitor cellsoxidative stress

More Related Videos

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

9.9K
A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

8.8K

Related Experiment Videos

Last Updated: Jul 23, 2025

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

9.4K
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

9.9K
A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

8.8K

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Cell Biology

Background:

  • Carvacrol, a phenolic monoterpene, exhibits antioxidant and antihypertensive properties.
  • Limited evidence exists on carvacrol's role in vascular regeneration.
  • Endothelial progenitor cells (EPCs) are crucial for repairing damaged blood vessels.

Purpose of the Study:

  • To investigate carvacrol's effect on endothelial repair mediated by EPCs in spontaneously hypertensive rats (SHR).
  • To assess carvacrol's impact on EPC function and vascular health in a hypertensive model.

Main Methods:

  • SHR and Wistar Kyoto (WKY) rats were treated with carvacrol, vehicle, or resveratrol for four weeks.
  • Systolic blood pressure (SBP) was monitored weekly.
  • EPCs were isolated, quantified, and their functionality assessed (CFU, eNOS, ROS, senescence).
  • Vascular tissues (superior mesenteric artery) were analyzed for ROS, CD34, and CD31 expression.

Main Results:

  • Carvacrol treatment improved EPC migration, colony-forming unit (CFU) formation, and eNOS expression/activity.
  • Carvacrol reduced intracellular reactive oxygen species (ROS) and senescence in EPCs.
  • Vascular ROS levels decreased, while CD31 and CD34 expression increased following carvacrol treatment.

Conclusions:

  • Carvacrol significantly enhances EPC functionality, contributing to improved endothelial repair.
  • Carvacrol demonstrates potential in mitigating endothelial dysfunction and promoting vascular health in hypertension.
  • These findings suggest carvacrol as a promising therapeutic agent for vascular regeneration.